Publication
Compliance Quarterly Türkiye
In this issue of our Compliance Quarterly Türkiye, we continue to inform our clients about the global and local compliance rules and regulations which impact Turkish businesses.
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Publication
In this issue of our Compliance Quarterly Türkiye, we continue to inform our clients about the global and local compliance rules and regulations which impact Turkish businesses.
Publication
On 13 November 2025, the European Parliament adopted (subject to certain amendments) the substantive Omnibus Directive which was proposed by the European Commission on 26 February 2025 (see our previous briefing here). The Omnibus proposal has now been referred to the Committee of Legal Affairs to proceed to the trilogue negotiations.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025